These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36345644)

  • 1. Time to address quality control processes applied to antibody testing for infectious diseases.
    Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
    Clin Chem Lab Med; 2023 Jan; 61(2):205-212. PubMed ID: 36345644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases.
    Dimech W
    Clin Microbiol Rev; 2021 Dec; 34(4):e0003521. PubMed ID: 34319148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
    Dimech W; Karakaltsas M; Vincini GA
    Clin Chem Lab Med; 2018 Oct; 56(11):1970-1978. PubMed ID: 29794255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Tony Badrick regarding "Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212 by".
    Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
    Clin Chem Lab Med; 2023 Jul; 61(8):e137-e139. PubMed ID: 36872632
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212.
    Badrick T
    Clin Chem Lab Med; 2023 Jul; 61(8):e135-e136. PubMed ID: 36866704
    [No Abstract]   [Full Text] [Related]  

  • 6. A modified quality control protocol for infectious disease serology based on the Westgard rules.
    Wang Y; Li X; Li D; Xie Y
    Sci Rep; 2024 Jul; 14(1):16683. PubMed ID: 39030224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterpoint to the Letter to the Editor by Badrick and Parvin in regard to Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
    Dimech W; Vincini G; Karakaltas M
    Clin Chem Lab Med; 2019 Apr; 57(5):e73-e74. PubMed ID: 30710479
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoserology of infectious diseases.
    James K
    Clin Microbiol Rev; 1990 Apr; 3(2):132-52. PubMed ID: 2187592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data.
    Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD
    Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lot release testing of serological infectious disease assays used for donor and donation screening.
    Kitchen AD; Newham JA
    Vox Sang; 2010 May; 98(4):508-16. PubMed ID: 20070648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing wisely in infectious serology: the merits of triaging send-away tests.
    Foley DA; Burge S; Tustin P; Blackmore T
    Pathology; 2019 Apr; 51(3):313-315. PubMed ID: 30808509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six Sigma driven QC in antibody testing for infectious diseases.
    Khelil MM
    Clin Chem Lab Med; 2024 Jan; 62(2):e40-e43. PubMed ID: 37559170
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality standards and guidelines for test validation for infectious diseases in veterinary laboratories.
    Newberry KM; Colling A
    Rev Sci Tech; 2021 Jun; 40(1):227-237. PubMed ID: 34140728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the patient response as an alternative to commercial negative quality control in infectious serology.
    Wils J; Boudewijns M; Vandermarliere M; Callewaert N
    J Clin Virol; 2015 Nov; 72():30-5. PubMed ID: 26363142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970-8.
    Badrick T; Parvin C
    Clin Chem Lab Med; 2019 Apr; 57(5):e71-e72. PubMed ID: 30904900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical Significance of Next-Generation Molecular Testing Systems for the Diagnosis of Infectious Diseases and Infection Control].
    Yamagishi Y; Mikamo H
    Rinsho Byori; 2014 Oct; 62(10):1003-12. PubMed ID: 27526549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On detection thresholds-a review on diagnostic approaches in the infectious disease laboratory and the interpretation of their results.
    Hahn A; Podbielski A; Meyer T; Zautner AE; Loderstädt U; Schwarz NG; Krüger A; Cadar D; Frickmann H
    Acta Trop; 2020 May; 205():105377. PubMed ID: 32007448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a change in quality control results influence the sensitivity of an anti-HCV test?
    Dimech WJ; Vincini GA; Cabuang LM; Wieringa M
    Clin Chem Lab Med; 2020 Jul; 58(8):1372-1380. PubMed ID: 32145056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious serology: interpretation of the results and traps to avoid].
    Huynen P; Melin P; Hayette MP; De Mol P
    Rev Med Liege; 2006 Dec; 61(12):827-33. PubMed ID: 17313119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.